n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyakawa, H | 1 |
| Mason, RP | 1 |
| Jiang, J | 1 |
| Kadiiska, MB | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Lipid-derived free radical production in superantigen-induced interstitial pneumonia.
Topics: Allopurinol; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Cell Movement; Deferoxamine; | 2009 |